Published in Hepatobiliary Pancreat Dis Int on May 01, 2003
Cavo-portal transposition in rat: a new simple model. BMC Surg (2007) 0.75
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int (2007) 1.56
Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2015) 1.39
Health-related quality of life of 256 recipients after liver transplantation. World J Gastroenterol (2012) 1.07
Is absolute lymphocyte count a good prognostic predictor in recurrence of hepatocellular carcinoma after liver transplantation? Transplantation (2014) 1.07
Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma. World J Gastroenterol (2013) 1.02
Up-regulation of IRAK-M is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in Kupffer cells. J Surg Res (2008) 0.99
Analysis of infections in the first 3-month after living donor liver transplantation. World J Gastroenterol (2012) 0.99
Clinical study on safety of adult-to-adult living donor liver transplantation in both donors and recipients. World J Gastroenterol (2007) 0.94
Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma. Cancer Lett (2008) 0.93
Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis. Eur J Gastroenterol Hepatol (2013) 0.92
Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Hepatobiliary Pancreat Dis Int (2010) 0.91
Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation. World J Gastroenterol (2012) 0.89
Oxidative DNA damage in peripheral leukocytes and its association with expression and polymorphisms of hOGG1: a study of adolescents in a high risk region for hepatocellular carcinoma in China. World J Gastroenterol (2003) 0.88
Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients. World J Gastroenterol (2009) 0.88
Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol (2008) 0.87
Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation. Hepatobiliary Pancreat Dis Int (2004) 0.87
Improved two-cuff technique for orthotopic liver transplantation in rat. Hepatobiliary Pancreat Dis Int (2004) 0.87
Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides. World J Gastroenterol (2004) 0.86
Hemihepatic versus total hepatic inflow occlusion during hepatectomy: a systematic review and meta-analysis. World J Gastroenterol (2011) 0.86
Orthotopic liver transplantation for patients with Caroli's disease. Hepatobiliary Pancreat Dis Int (2008) 0.86
Staging of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2003) 0.85
Predictors of patient survival following living donor liver transplantation. Hepatobiliary Pancreat Dis Int (2011) 0.84
Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation. Ann Hepatol (2012) 0.84
Preoperative predictors of portal vein thrombosis after splenectomy with periesophagogastric devascularization. World J Gastroenterol (2012) 0.84
Incidence and treatment of hepatic artery complications after orthotopic liver transplantation. World J Gastroenterol (2003) 0.84
Caudate lobectomy by the third porta hepatis anatomical method: a study of 16 cases. Hepatobiliary Pancreat Dis Int (2006) 0.83
Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy. Hepatogastroenterology (2012) 0.83
Analysis of CD8+CD28- T-suppressor cells in living donor liver transplant recipients. Hepatobiliary Pancreat Dis Int (2009) 0.83
Evaluation of standard liver volume formulae for Chinese adults. World J Gastroenterol (2009) 0.83
Effect of apolipoprotein E gene Hha I restricting fragment length polymorphism on serum lipids in cholecystolithiasis. World J Gastroenterol (1999) 0.82
Graft size alone should not affect donors selection and be used to predict the prognosis of recipients after living donor liver transplantation. Hepatogastroenterology (2012) 0.82
Liver transplantation for patients with hepatolithiasis. Hepatobiliary Pancreat Dis Int (2005) 0.82
Protective effect of nitric oxide induced by ischemic preconditioning on reperfusion injury of rat liver graft. World J Gastroenterol (2004) 0.82
Randomized comparison of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infection. Asian J Surg (2004) 0.82
A successful pregnancy following liver transplantation. Hepatobiliary Pancreat Dis Int (2007) 0.82
Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells. Hepatobiliary Pancreat Dis Int (2006) 0.81
Safety of living donor liver transplantation using older donors. J Surg Res (2012) 0.81
Delayed internal pancreatic fistula with pancreatic pleural effusion postsplenectomy. World J Gastroenterol (2010) 0.81
Treatment of hepatic venous outflow stenosis after living donor liver transplantation by insertion of an expandable metallic stent. Hepatobiliary Pancreat Dis Int (2009) 0.81
Evaluation of oxidative stress in a group of adolescents exposed to a high level of aflatoxin B1--a multi-center and multi-biomarker study. Carcinogenesis (2007) 0.81
Microsurgical reconstruction of hepatic artery in A-A LDLT: 124 consecutive cases without HAT. World J Gastroenterol (2010) 0.81
Zinc finger protein A20 protects rats against chronic liver allograft dysfunction. World J Gastroenterol (2012) 0.80
Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma. Hepatogastroenterology (2008) 0.80
Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation. World J Gastroenterol (2010) 0.80
Measures for increasing the safety of donors in living donor liver transplantation using right lobe grafts. Hepatobiliary Pancreat Dis Int (2007) 0.80
Risks faced by donors of right lobe for living donor liver transplantation. Hepatobiliary Pancreat Dis Int (2009) 0.80
Is correction for protein concentration appropriate for protein adduct dosimetry? Hypothesis and clues from an aflatoxin B1-exposed population. Cancer Sci (2007) 0.80
Hepatic venous outflow reconstruction in right lobe graft without middle hepatic vein. Hepatol Res (2007) 0.80
Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report. Hepatobiliary Pancreat Dis Int (2003) 0.80
Problems in adult living donor liver transplantation using the right hepatic lobe. Hepatobiliary Pancreat Dis Int (2006) 0.79
Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy. World J Gastroenterol (2013) 0.79
Improved early diagnosis of cystadenocarcinoma of the pancreas. Hepatobiliary Pancreat Dis Int (2007) 0.79
Zinc finger protein A20 promotes regeneration of small-for-size liver allograft and suppresses rejection and results in a longer survival in recipient rats. J Surg Res (2008) 0.79
Donor safety and remnant liver volume in living donor liver transplantation. World J Gastroenterol (2012) 0.79
Evaluation outcomes of donors in living donor liver transplantation: a single-center analysis of 132 donors. Hepatobiliary Pancreat Dis Int (2011) 0.79
Overexpression of TIMP-1 mediated by recombinant adenovirus in hepatocellular carcinoma cells inhibits proliferation and invasion in vitro. Hepatobiliary Pancreat Dis Int (2006) 0.79
Retrospective analysis of prognostic factors after liver transplantation for intrahepatic cholangiocarcinoma in China: a single-center experience. Hepatogastroenterology (2011) 0.79
Factors associated with early mortality after living-donor liver transplant. Exp Clin Transplant (2014) 0.78
Combined hepatectomy and radiofrequency ablation versus TACE in improving survival of patients with unresectable BCLC stage B HCC. Hepatobiliary Pancreat Dis Int (2016) 0.78
Augmented regeneration of partial liver allograft induced by nuclear factor-kappaB decoy oligodeoxynucleotides-modified dendritic cells. World J Gastroenterol (2004) 0.78
Effects of epidermal growth factor receptor inhibitor genistein on proliferative cholangitis in rats. J Surg Res (2009) 0.78
Causes of mortality after liver transplantation: a single center experience in mainland china. Hepatogastroenterology (2012) 0.78
Prophylaxis of chronic kidney disease after liver transplantation--experience from west China. World J Gastroenterol (2012) 0.78
Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol (2009) 0.78
Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation. PLoS One (2013) 0.78
Quality of life and psychological outcome of donors after living donor liver transplantation. World J Gastroenterol (2012) 0.78
Nuclear factor-kappaB decoy oligodeoxynucleotides attenuates ischemia/reperfusion injury in rat liver graft. World J Gastroenterol (2005) 0.78
Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection. J Gastrointest Surg (2014) 0.78
Effect of peroxisome proliferator-activated receptor-gamma ligand on inflammation of human gallbladder epithelial cells. World J Gastroenterol (2005) 0.78
Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations. World J Gastroenterol (2011) 0.78
Posttraumatic stress disorder after liver transplantation. Hepatobiliary Pancreat Dis Int (2012) 0.78
Retrospective study of steroid therapy for patients with autoimmune pancreatitis in a Chinese population. World J Gastroenterol (2013) 0.78
Up-to-seven criteria for hepatocellular carcinoma liver transplantation: a single center analysis. World J Gastroenterol (2013) 0.78
The pre-Kasai procedure in living donor liver transplantation for children with biliary atresia. Hepatobiliary Pancreat Dis Int (2013) 0.77
Intramuscular hepatitis B immune globulin combined with lamivudine in prevention of hepatitis B recurrence after liver transplantation. Hepatobiliary Pancreat Dis Int (2006) 0.77
Risk factors of SFSS in adult-to-adult living donor liver transplantation using the right liver: a single-center analysis of 217 cases. Hepatogastroenterology (2012) 0.77
Changed clinical aspects of primary liver cancer in China during the past 30 years. Hepatobiliary Pancreat Dis Int (2004) 0.77
Adult-to-adult living donor liver transplantation for malignant metastatic melanoma to the liver. Hepatobiliary Pancreat Dis Int (2010) 0.77
Is hepatectomy for huge hepatocellular carcinoma (≥ 10 cm in diameter) safe and effective? A single-center experience. Asian Pac J Cancer Prev (2014) 0.77
Facing up to the threat in China. Lancet (2010) 0.77
Recent advances in liver-directed gene transfer vectors. Hepatobiliary Pancreat Dis Int (2004) 0.77
Microproteinuria for detecting calcineurin inhibitor-related nephrotoxicity after liver transplantation. World J Gastroenterol (2009) 0.76
Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R. World J Gastroenterol (2002) 0.76
Management of venous stenosis in living donor liver transplant recipients. World J Gastroenterol (2009) 0.76
Postoperative complications after liver transplantation with cavoportal hemitransposition. Hepatobiliary Pancreat Dis Int (2008) 0.76
"Metroticket" predictor for assessing liver transplantation to treat hepatocellular carcinoma: a single-center analysis in mainland China. World J Gastroenterol (2013) 0.76
[Diagnosis and treatment of intrahepatic biliary cystadenocarcinoma-a report of 11 cases]. Ai Zheng (2007) 0.76
[Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration]. Ai Zheng (2007) 0.76
Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B. World J Gastroenterol (2008) 0.76
A rare case of periampullary carcinoma with ectopic ending of Vater's ampulla. World J Gastroenterol (2009) 0.75
Autologous transfusion with modified total hepatic vascular exclusion for extracapsular resection of giant hepatic cavernous hemangioma. Hepatobiliary Pancreat Dis Int (2007) 0.75
Pregnancy after liver transplantation: four-year follow-up of the first case in mainland China. World J Gastroenterol (2008) 0.75
Donor safety in adult living donor liver transplantation using the right lobe: single center experience in China. World J Gastroenterol (2007) 0.75
Hepatic adenylate energy charge levels in patients with hepatoma after hepatic artery embolization. World J Gastroenterol (1998) 0.75
Construction of recombinant adenoviral vector carrying human tissue inhibitor of metalloproteinase-1 gene and its expression in vitro. Hepatobiliary Pancreat Dis Int (2005) 0.75
[Regulatory function of tacrolimus and CsA on CD4/CD8 T lymphocyte subgroups and costimulators on them in allo-liver recipients]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2008) 0.75
Development and validation of a predictive score for perioperative transfusion in patients with hepatocellular carcinoma undergoing liver resection. Hepatobiliary Pancreat Dis Int (2015) 0.75
Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria. Hepatobiliary Pancreat Dis Int (2013) 0.75
Risk factors for abdominal bleeding after living-donor liver transplant. Exp Clin Transplant (2014) 0.75
[Reconstruction of hepatic artery in adult to adult living donor liver transplantation in 104 patients]. Zhonghua Yi Xue Za Zhi (2009) 0.75